MORGAN STANLEY PLC/CALL/PFIZER INC/60/0.1/17.01.25 Stock

Warrant

DE000MB32H08

Market Closed - Börse Stuttgart 14:32:54 2024-05-29 EDT
0.009 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/60/0.1/17.01.25
Current month-30.77%
1 month-18.18%
Date Price Change
24-05-29 0.009 0.00%
24-05-28 0.009 +12.50%
24-05-27 0.008 -11.11%
24-05-24 0.009 0.00%
24-05-23 0.009 -10.00%

Delayed Quote Börse Stuttgart

Last update May 29, 2024 at 02:32 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB32H0
ISINDE000MB32H08
Date issued 2023-02-01
Strike 60 $
Maturity 2025-01-17 (233 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.191
Lowest since issue 0.006
Spread 0.031
Spread %77.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.82 USD
Average target price
31.92 USD
Spread / Average Target
+14.72%
Consensus